(Q42978707)

English

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients

scientific article published on August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Richard van Altena

2

object named as

Richard van Altena

0 references

Dick van Soolingen

7

object named as

Dick van Soolingen

1 reference

Europe PubMed Central

12 November 2017

Tjip S van der Werf

object named as

Tjip S van der Werf

10

1 reference

ORCID Public Data File 2021

author name string

Jan-Willem C Alffenaar

1

1 reference

Europe PubMed Central

12 November 2017

Richard van Altena

2

1 reference

Europe PubMed Central

12 November 2017

Ilse M Harmelink

3

1 reference

Europe PubMed Central

12 November 2017

Patricia Filguera

4

1 reference

Europe PubMed Central

12 November 2017

Esther Molenaar

5

1 reference

Europe PubMed Central

12 November 2017

A Mireille A Wessels

6

1 reference

Europe PubMed Central

12 November 2017

Jos G W Kosterink

8

1 reference

Europe PubMed Central

12 November 2017

Donald R A Uges

9

1 reference

Europe PubMed Central

12 November 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

12 November 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

12 November 2017

49

1 reference

Europe PubMed Central

12 November 2017

8

1 reference

Europe PubMed Central

12 November 2017

559-565

1 reference

Europe PubMed Central

12 November 2017

https://scigraph.springernature.com/pub.10.2165/11532080-000000000-00000

0 references

Improved outcomes for patients with multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.2165%2F11532080-000000000-00000

21 January 2018

Predictors and outcome of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.2165%2F11532080-000000000-00000

21 January 2018

Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid, an agent from a new class of antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms for linezolid-induced anemia and thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of multidrug-resistant tuberculosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does the dose matter?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of food on plasma and tissue concentrations of linezolid after multiple doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid for the treatment of multidrug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid-associated toxic optic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reliability of assessment of vibration sense

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid and rifampin: Drug interaction contrary to expectations?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method

1 reference

https://pubmed.ncbi.nlm.nih.gov/20608757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11532080-000000000-00000

1 reference

Europe PubMed Central

12 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42978707&oldid=2143810256"